EX-99 3 q424ex-992q4prereleaseq4on.htm EX-99.2

Exhibit 99.2

Intuitive Surgical, Inc.

Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics

			Three Months Ended																		Twelve Months Ended
			December 31, 2024						December 31, 2023						Change						December 31, 2024						December 31, 2023						Change
Revenue ($millions)
Instruments and accessories (“I&A”)			$	1,411.5					$	1,143.7					23		%				$	5,079.0					$	4,276.6					19		%
Systems			654.6						480.2						36		%				1,966.0						1,679.7						17		%
Services			347.4						304.4						14		%				1,307.1						1,167.8						12		%
Total revenue			$	2,413.5					$	1,928.3					25		%				$	8,352.1					$	7,124.1					17		%
% Total recurring revenue (1)			80%						82%												84%						83%
Da Vinci Surgical System Placements by Geography
United States			284						209						36		%				800						666						20		%
Europe			89						71						25		%				309						308						—		%
Asia			96						110						(13)		%				321						305						5		%
Other markets			24						25						(4)		%				96						91						5		%
Total system placements*			493						415						19		%				1,526						1,370						11		%
Unit placements involving trade-ins			62						51						22		%				150						240						(38)		%
Da Vinci Surgical System Placements by Model
Dual Console da Vinci X Systems			2						—						N/M						5						4						25		%
Single Console da Vinci X Systems			47						46						2		%				170						176						(3)		%
Dual Console da Vinci Xi Systems			76						99						(23)		%				223						328						(32)		%
Single Console da Vinci Xi Systems			164						251						(35)		%				670						805						(17)		%
Dual Console da Vinci 5 Systems			46						—						N/M						58						—						N/M
Single Console da Vinci 5 Systems			128						—						N/M						304						—						N/M
Da Vinci SP Systems			30						19						58		%				96						57						68		%
Total system placements*			493						415						19		%				1,526						1,370						11		%
*Systems placed under fixed-payment operating lease arrangements (included in total unit placements)			82						92						(11)		%				309						304						2		%
*Systems placed under usage-based operating lease arrangements (included in total unit placements)			140						109						28		%				467						355						32		%
Ion System Placements**			69						44						57		%				271						213						27		%
**Systems placed under fixed-payment operating lease arrangements (included in total unit placements)			24						14						71		%				85						63						35		%
**Systems placed under usage-based operating lease arrangements (included in total unit placements)			14						15						(7)		%				68						54						26		%
Other da Vinci Surgical System Metrics
Procedures (thousands)			725						613						18		%				2,683						2,286						17		%
Average Selling Price ($millions)			$	1.59					$	1.42					12		%				$	1.50					$	1.42					5		%
I&A revenue per procedure ($thousands)			$	1.86					$	1.80					3		%				$	1.81					$	1.82					—		%
Installed base (2)			9,902						8,606						15		%				9,902						8,606						15		%

(1) We present operating lease revenue, which is classified as systems revenue, as a component of total recurring revenue.

(2) During the fourth quarters of 2024 and 2023, we performed a verification audit of our installed base records that identified 54 and 41 systems, respectively, mostly older S and Si models, which had been retired. We removed these systems from our installed base estimate during the fourth quarters of 2024 and 2023, respectively.

Page 1 of 2

---

Intuitive Surgical, Inc.

Unaudited Preliminary Trended Annual da Vinci Procedure Data

						Approximate Procedures (Thousands)																		Percentage Change*
						Years Ended December 31,																		Years Ended December 31,
						2024						2023						2022						2024						2023
United States
General Surgery						1,063						896						720						19		%				25		%
Gynecology						423						390						341						8		%				15		%
Urology						186						173						162						7		%				7		%
Other						85						73						59						18		%				20		%
Total United States						1,757						1,532						1,282						15		%				19		%
Outside of the United States
Urology						435						381						316						14		%				21		%
General Surgery						254						188						133						35		%				42		%
Other						237						185						144						28		%				29		%
Total Outside of the United States						926						754						593						23		%				27		%
Total Worldwide						2,683						2,286						1,875						17		%				22		%
* The approximate procedures are rounded to thousands, but the percentage changes are based on unrounded approximate procedures.

This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements relate to unaudited preliminary trended annual procedure data, unaudited preliminary fourth quarter and full year 2024 revenue data and metrics, and other related subjects. The unaudited preliminary results are subject to the completion of Intuitive’s final closing procedures and an audit by Intuitive’s independent registered accounting firm and, therefore, are subject to adjustment. These forward-looking statements are based on Intuitive’s current expectations and estimates and are subject to risks and uncertainties that could cause actual events and results to vary significantly from those implied by such statements. These forward-looking statements should, therefore, be considered in light of various important factors, including, but not limited to, the following: completion of Intuitive’s final closing procedures, final adjustments, and other developments that may arise in the course of audit and review procedures; and other risk factors under the heading “Risk Factors” in Intuitive’s Annual Report on Form 10-K for the year ended December 31, 2023, as updated by Intuitive’s other filings with the Securities and Exchange Commission.

Page 2 of 2